M Lebwohl1, E Abel, M Zanolli, J Koo, L Drake. Show Affiliations » 1. Department of Dermatology, Mt. Sinai School of Medicine, New York, New York, USA.
Abstract
Entities: Disease
Mesh： See more » Administration, CutaneousAdministration, TopicalAnthralin/administration & dosageAnthralin/adverse effectsAnthralin/therapeutic useAnti-Inflammatory Agents/administration & dosageAnti-Inflammatory Agents/adverse effectsAnti-Inflammatory Agents/therapeutic useCholecalciferol/administration & dosageCholecalciferol/adverse effectsCholecalciferol/analogs & derivativesCholecalciferol/therapeutic useDermatologic Agents/administration & dosageDermatologic Agents/adverse effectsDermatologic Agents/therapeutic useGlucocorticoidsHumansPUVA Therapy/adverse effectsPUVA Therapy/methodsPsoriasis/drug therapyTars/adverse effectsTars/therapeutic use
Substances： See more » Anti-Inflammatory AgentsDermatologic AgentsGlucocorticoidsTarsCholecalciferolAnthralin
Year: 1995 PMID： 8537153
Source DB: PubMed Journal: Int J Dermatol ISSN： 0011-9059 Impact factor: 2.736